Hirosaki LI announces that the marketing authorization for the human (autologous) oral mucosa-derived epithelial cell sheet using human amniotic membrane substrate Sakracy (development code: TR9) has been deliberated and approved.

ヒト羊膜基質使用ヒト（自己）口腔粘膜由来上皮細胞シート「サクラシー」（開発名：TR9）部会了承に関するお知らせ